Sign in
Enrolling by invitationNo phase

Using brain waves and reaction tests to detect minimal hepatic encephalopathy in cirrhosis

Compares brain wave recordings with reaction time tests in people with liver cirrhosis.

Key facts

Who runs it
Esbjerg Hospital - University Hospital of Southern Denmark
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Diagnosing Minimal Hepatic Encephalopathy
Status
Enrolling by invitation
People taking part
550 people, planned
Started
1 Dec 2019
Expected to end
1 Dec 2031
Type of study
Observational, 6 groups
Treatments tested
  • Simultaneous EEG and CRT
Record updated
2 December 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with liver cirrhosis, with or without brain effects from liver disease (hepatic encephalopathy). It also takes healthy people, people with earlier-stage liver disease, and people with other long-term diseases as comparison groups.

Age
18 Years to 90 Years.
Sex
All sexes.
Disease stage
Liver cirrhosis confirmed by biopsy, or by clinical signs, blood tests and imaging. Groups: normal thinking tests, minimal hepatic encephalopathy, or HE grade 2 or more. Also pre-cirrhosis liver disease, mostly NAFLD, seen in the local outpatient clinic.
Biomarker or test result
Thinking test results (PSE and CRT) decide the group: normal, or abnormal results.

Main reasons for not taking part

  • Brain or nerve diseases such as epilepsy, stroke or dementia.
  • Low blood sodium (Na <124 mmol / L) or sepsis in the week before tests.
  • Heart failure (EC less than 30% or NYHA class III and IV) or severe COPD (GOLD stage 3 and 4).
  • Poorly controlled diabetes (HbA1C> 60 mmol / mol) or kidney failure (eGFR below 60).
  • Coffee or alcohol within 6 hours before tests, or a dose change of mind-affecting drugs within 6 days.

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Age> 18
  • Liver cirrhosis verified by biopsy or appropriate clinic and biochemistry as well as imaging
  • Written informed consent
  • Speaks and understands Danish; For the subgroup with liver cirrhosis and normal cognition:
  • Normal result in PSE and CRT testing and clinical examination without evidence of HE; For the subgroup with liver cirrhosis and minimal hepatic encephalopathy:
  • Abnormal result in PSE and / or CRT test, but oriented in time, place and own data; For the subgroup with liver cirrhosis and HE grade 2, the following applies:
  • Abnormal PSE and CRT result and / or disoriented in time, place or own data and / or asterixis or other clinical symptoms of HE
  • Ability to collaborate on the performance of CRT test, PSE test and EEG
  • Liver healthy
  • Age over 18 years
  • Formal education ≤ 14 years
  • Written informed consent
  • Speaks and understands Danish
  • As for healthy controls plus:
  • In our local outpatient clinic
  • Proven pre-cirrhosis liver disease

Who cannot take part

  • Organic brain disease (eg previous epilepsy, apoplexy, dementia)
  • Sepsis one week prior to tests
  • Intake of coffee or alcohol 6 hours before tests and change of dose in psychoactive drugs within 6 days of the test (morphine, antipsychotics, antidepressants) -
  • Heart failure (EC less than 30% or NYHA class III and IV)
  • Severe chronic obstructive pulmonary disease (GOLD stage 3 and 4 ie FEV1 / FVC below 0.7 and FEV1 <50% of expected value)
  • Known neurological diseases (epilepsy, stroke, dementia)
  • Highly controllable diabetes (HbA1C> 60 mmol / mol)
  • Renal failure (eGFR below 60)
  • Hyponatraemia (Na <124 mmol / L)

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Our purpose is to

Read full original descriptionShow less

1. Examine the correlation between MDF in a resting EEG, recorded just before the CRT test, and the variance in reaction times indicated by the CRT index 2. At simultaneous CRT and EEG recording, examine whether a change in EEG is seen immediately before an extended reaction time occurs (defined by the 75th percentile). This will shed light on a direct pathophysiological association between what is measured with EEG and CRT. 3. Investigate whether cyclicity can be detected in the continuous reaction times and if so, whether amplitude and wavelength in this cyclic activity are correlated to EEG parameters. 4. Examine whether a response to standard HE treatment can be detected with EEG in patients who are thought to suffer from it. As well as if baseline outcome predict future hepatic encephalopathy. 5. With a view to further validating our findings, investigators want to correlate results from EEG and CRT with the most internationally widespread psychometric test, the Portosystemic Encephalopathy test (PSE), which necessitates the establishment of Danish normal values. A secondary purpose of this study is therefore 6. To establish Danish normal values for the PSE test and the Animal Naming test in Danes

The 6 groups in the trial

  • Liver cirrhosis with normal cognition

    Liver cirrhosis and performs normally in all psychometric tests. n=100

    Treatment: Simultaneous EEG and CRT

  • Liver cirrhosis with minimal hepatic encephalopathy

    Liver cirrhosis and performs abnormally en 2 or more psychometric test. n=100

    Treatment: Simultaneous EEG and CRT

  • Liver cirrhosis and overt hepatic encephalopathy

    West Haven grade 2 or more. n=50

    Treatment: Simultaneous EEG and CRT

  • Healthy control persons

    Completely healthy persons, age, and gender-matched to cirrhosis patients. n=100

    Treatment: Simultaneous EEG and CRT

  • Sick control persons

    Persons with other chronic diseases than liver disease. n=100

    Treatment: Simultaneous EEG and CRT

  • Pre-cirrhotic liver disease

    Not yet cirrhosis. Will primarily be NAFLD patients. n=100

    Treatment: Simultaneous EEG and CRT

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Diagnostik Af Minimal Hepatisk Encephalopati: Association Mellem Kontinuert Reaktionsstidsmåling Og EEG-indices
Plain-language title
Using brain waves and reaction tests to detect minimal hepatic encephalopathy in cirrhosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT05433948, who can take part
Record updated
2 December 2024